2-[4-(4-Fluorophenyl)piperazin-1-yl]-N-(4-methoxyphenyl)acetamide

Catalog No. :
ACCQKA093
CAS No. :
303091-64-7
Molecular Formula :
C19H22FN3O2
Molecular Weight :
343.40

IUPAC Name:2-(4-(4-fluorophenyl)piperazin-1-yl)-N-(4-methoxyphenyl)acetamide

2-[4-(4-Fluorophenyl)piperazin-1-yl]-N-(4-methoxyphenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-[4-(4-Fluorophenyl)piperazin-1-yl]-N-(4-methoxyphenyl)acetamide
IUPAC Name2-(4-(4-fluorophenyl)piperazin-1-yl)-N-(4-methoxyphenyl)acetamide
MDL No.MFCD02675257
Molecular FormulaC19H22FN3O2
Molecular Weight343.40
SMILESO=C(NC1=CC=C(OC)C=C1)CN2CCN(C3=CC=C(F)C=C3)CC2
InChI KeySPSHLRKZYICJCO-UHFFFAOYSA-N
Synonym2-[4-(4-FLUOROPHENYL)PIPERAZINO]-N-(4-METHOXYPHENYL)ACETAMIDE;2-[4-(4-fluorophenyl)piperazin-1-yl]-N-(4-methoxyphenyl)acetamide;1-Piperazineacetamide, 4-(4-fluorophenyl)-N-(4-methoxyphenyl)-
CAS No.303091-64-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACCQKA093 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNSPL652 route compound structure diagram
    ACNSPL65222303-36-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCQKA093 route product structure diagram
    ACCQKA093303091-64-7
Inquiry

2. ACCQKA093 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTNVG814 route compound structure diagram
    ACTNVG81429182-87-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCQKA093 route product structure diagram
    ACCQKA093303091-64-7
Inquiry

Comments (0)